CAS No |
Product Name |
Molecular Formula |
1045855-91-1
|
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo(3,2-b)pyridine
|
C13H17BN2O2
|
1046153-00-7
|
6-Oxa-1-azaspiro(3.3)heptane;Ring Parent
|
C5H9NO
|
1046153-04-1
|
2-Oxa-5-azaspiro(3.5)nonane
|
C7H13NO
|
1046153-20-1
|
2-Oxa-6-azaspiro(3.5)nonane
|
C7H13NO
|
1046494-85-2
|
2-((4-Formylphenoxy)methyl)benzoic acid methyl ester
|
C16H14O4
|
1046786-08-6
|
((Oxido)phenyl(trifluoromethyl)sulfanylidene)dimethylammonium tetrafluoroborate
|
C9H11F3NOS.BF4
|
1046787-18-1
|
((2S,5R)-2,5-Dimethyl-4-((tetrahydro-2H-pyran-4-yl)methyl)-1-piperazinyl)(3-((5-fluoro-2-methyl-4-pyrimidinyl)amino)-4,6-dihydro-6,6-dimethylpyrrolo(3,4-c)pyrazol-5(1H)-yl)methanone
|
C25H37FN8O2
|
1046788-78-6
|
(2R,5S)-1,2,5-Trimethylpiperazine
|
C7H16N2
|
1046806-02-3
|
((3S,3'S,4S,4'S,11bR,11'bR)-4,4'-Bis(1,1-dimethylethyl)-4,4',5,5'-tetrahydro-3,3'-bi-3H-dinaphtho(2,1-c:1',2'-e)phosphepin)((1,2,5,6-eta)-1,5-cyclooctadiene)rhodium tetrafluoroborate
|
C60H60P2Rh.BF4
|
1046811-99-7
|
3,4-Dihydro-2H-pyran-5-boronic acid pinacol ester;2-(3,4-Dihydro-2H-pyran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
C11H19BO3
|
1046812-02-5
|
2,3-Dihydro-5-furylboronic acid pinacol ester;2-(4,5-Dihydrofuran-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
C10H17BO3
|
1046812-03-6
|
4,5-Dihydrofuran-3-boronic acid pinacol ester;2-(4,5-Dihydrofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
C10H17BO3
|
1046815-82-0
|
3-(1-(5-Ethylpyrimidin-2-yl)piperidin-4-yl)propan-1-ol
|
C14H23N3O
|
1046816-38-9
|
3-Chloro-6-cyclopropylpyridazine
|
C7H7ClN2
|
1046816-75-4
|
2-Chloro-5-pyrimidinemethanol;(2-Chloropyrimidin-5-yl)methanol; 2-Chloro-5-(hydroxymethyl)pyrimidine
|
C5H5ClN2O
|
1046817-22-4
|
1-Methylcyclopropyl 4-nitrophenyl carbonate;4-Nitrophenyl 1-methylcyclopropyl carbonate
|
C11H11NO5
|
1046831-97-3
|
4-Bromo-1-(trifluoromethyl)-1H-pyrazole
|
C4H2BrF3N2
|
1046831-98-4
|
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(trifluoromethyl)-1H-pyrazole
|
C10H14BF3N2O2
|
1046832-21-6
|
(1,3-Dimethyl-1H-pyrazol-4-yl)boronic acid pinacol ester;1,3-Dimethyl-4-(4,4,5,5-tetramethyl-(1,3,2)dioxaborolan-2-yl)-1H-pyrazole
|
C11H19BN2O2
|
1046861-20-4
|
(4-Bromo-2-chlorophenyl)boronic acid
|
C6H5BBrClO2
|
1047630-72-7
|
4-Bromo-5-chloro-2-thiophenecarboxylic acid methyl ester
|
C6H4BrClO2S
|
1047634-63-8
|
GSK 2110183;N-((1S)-2-Amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide
|
C18H16Cl2F2N4OS
|
1047634-65-0
|
Uprosertib;N-((1S)-2-Amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide; GSK 2141795C
|
C18H16Cl2F2N4O2
|
1047644-62-1
|
Afuresertib;N-((1S)-2-Amino-1-((3-fluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide; GSK 2110183C
|
C18H17Cl2FN4OS
|
1047651-73-9
|
(3S,4R)-4-o-Tolylpyrrolidine-3-carboxylic acid
|
C12H15NO2
|
1047651-74-0
|
(3S,4R)-4-(3-Bromophenyl)pyrrolidine-3-carboxylic acid
|
C11H12BrNO2
|
1047651-79-5
|
(3S,4R)-4-(2-Chlorophenyl)pyrrolidine-3-carboxylic acid
|
C11H12ClNO2
|
1047651-82-0
|
(3S,4R)-4-(4-Chlorophenyl)pyrrolidine-3-carboxylic acid
|
C11H12ClNO2
|
1047651-83-1
|
(3S,4R)-4-(2-Bromophenyl)pyrrolidine-3-carboxylic acid
|
C11H12BrNO2
|
1047684-56-9
|
4,4'-Bis(5-hexyl-2-thienyl)-2,2'-bipyridine;4-(5-hexylthiophen-2-yl)-2-(4-(5-hexylthiophen-2-yl)pyridin-2-yl)pyridine
|
C30H36N2S2
|
1047724-24-2
|
2-((Methylsulfonyl)amino)benzeneacetic acid
|
C9H11NO4S
|
1047953-91-2
|
2-Chloro-N-(4-(5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl)phenyl)-Acetamide
|
C19H17Cl3N4O3
|
1048007-93-7
|
Masitinib mesylate;4-((4-Methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-thiazolyl)amino)phenyl)benzamide methanesulfonate (1:1)
|
C28H30N6OS.CH4O3S
|
1048007-94-8
|
N-(2-Methyl-5-nitrophenyl)-4-(3-pyridinyl)-2-thiazolamine
|
C15H12N4O2S
|
1048038-90-9
|
N-(Adamant-1-yl)-6-isopropyl-4-oxo-1-pentyl-1,4-dihydroquinolin-3-carboxamide
|
C28H38N2O2
|
1048330-10-4
|
5-Borono-2-methylbenzoic acid 1-methyl ester
|
C9H11BO4
|
1048371-03-4
|
UPF 1069;5-(2-Oxo-2-phenylethoxy)-1(2H)-isoquinolinone
|
C17H13NO3
|
1048383-29-4
|
7-(3-Chloro-5-(trifluoromethyl)-2-pyridinyl)-5-methyl-(1,2,4)triazolo(1,5-a)pyrimidine
|
C12H7ClF3N5
|
1048647-68-2
|
N-(Phenylmethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
|
C20H24BNO3
|
1048679-01-1
|
3',3''-Diphenyl-3'H,3''H-dicyclopropa(1,9:52,60)(5,6)fullerene-C60-Ih-3',3''-dibutanoic acid 3',3''-dimethyl ester
|
C84H28O4
|
1048914-10-8
|
3-Bromo-5-(trifluoromethyl)-1H-pyrrolo(2,3-b)pyridine
|
C8H4BrF3N2
|
1048920-45-1
|
3-(2-Aminoethyl)-1-pyrrolidinecarboxylic acid tert-butyl ester
|
C11H22N2O2
|
1048921-49-8
|
2,6-Difluoro-3-trifluoromethylbenzoic acid
|
C8H3F5O2
|
1048948-15-7
|
Olmesartan medoxomil Cyclic impurty N2-Trityl;3,6-Dihydro-6,6-diMethyl-2-propyl-3-((2'-(2-(triphenylMethyl)-2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)Methyl)-4H-furo(3,4-d)iMidazol-4-one
|
C43H38N6O2
|
1048962-82-8
|
(3R)-Tetrahydro-3-furanmethanamine
|
C5H11NO
|
1048962-84-0
|
(3S)-Tetrahydro-3-furanmethanamine
|
C5H11NO
|
1048970-17-7
|
1-Boc-piperidin-4-ylboronic acid pinacol ester
|
C16H30BNO4
|
1048973-47-2
|
Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide;MDA 19
|
C21H23N3O2
|
1048976-83-5
|
1-Benzyl-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester;1,2,3,6-Tetrahydro-1-(phenylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
C18H26BNO2
|
1049004-32-1
|
1-Ethoxycarbonylcyclohex-3-ene-4-boronic acid pinacol ester;4-(4,4,5,5-Tetramethyl-(1,3,2)dioxaborolan-2-yl)cyclohex-3-ene-1-carboxylic acid ethyl ester
|
C15H25BO4
|